

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.82984215 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.78320559 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.08631145 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.78078319 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.74287278 |
| 6 | layer formation in cerebral cortex (GO:0021819) | 4.69089027 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.50815620 |
| 8 | vocalization behavior (GO:0071625) | 4.33190043 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.30899704 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25169699 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.24078942 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.21970166 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.19420137 |
| 14 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.16922087 |
| 15 | regulation of ARF protein signal transduction (GO:0032012) | 4.12001057 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 4.09496151 |
| 17 | glutamate secretion (GO:0014047) | 4.09389461 |
| 18 | exploration behavior (GO:0035640) | 4.07264326 |
| 19 | sodium ion export (GO:0071436) | 4.01875192 |
| 20 | mannose metabolic process (GO:0006013) | 4.01109309 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.90355726 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.90355726 |
| 23 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.76389767 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 3.70794045 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 3.69659523 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58265670 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.56913549 |
| 28 | regulation of ARF GTPase activity (GO:0032312) | 3.54703612 |
| 29 | protein localization to synapse (GO:0035418) | 3.53703278 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.51257111 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 3.51168560 |
| 32 | neurotransmitter secretion (GO:0007269) | 3.49010533 |
| 33 | proline transport (GO:0015824) | 3.45460956 |
| 34 | activation of protein kinase A activity (GO:0034199) | 3.41411343 |
| 35 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.41306484 |
| 36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.40026047 |
| 37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36394722 |
| 38 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.32699920 |
| 39 | activation of Rac GTPase activity (GO:0032863) | 3.28945428 |
| 40 | semaphorin-plexin signaling pathway (GO:0071526) | 3.27291958 |
| 41 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.25067698 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.21162583 |
| 43 | negative regulation of microtubule polymerization (GO:0031115) | 3.19607570 |
| 44 | neuromuscular process controlling balance (GO:0050885) | 3.14621653 |
| 45 | positive regulation of histone deacetylation (GO:0031065) | 3.13263974 |
| 46 | cell migration in hindbrain (GO:0021535) | 3.12863416 |
| 47 | cellular potassium ion homeostasis (GO:0030007) | 3.09948516 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.09608584 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.07843191 |
| 50 | positive regulation of membrane potential (GO:0045838) | 3.06388415 |
| 51 | germinal center formation (GO:0002467) | 3.06022731 |
| 52 | long-term memory (GO:0007616) | 3.05701520 |
| 53 | auditory behavior (GO:0031223) | 3.04549234 |
| 54 | positive regulation of Rap GTPase activity (GO:0032854) | 3.04466974 |
| 55 | endothelial cell chemotaxis (GO:0035767) | 3.03760908 |
| 56 | activation of MAPKKK activity (GO:0000185) | 3.01896512 |
| 57 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.01551097 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.96700835 |
| 59 | prepulse inhibition (GO:0060134) | 2.94613965 |
| 60 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.93249019 |
| 61 | dendrite morphogenesis (GO:0048813) | 2.93195046 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 2.93094630 |
| 63 | clathrin coat assembly (GO:0048268) | 2.92317190 |
| 64 | regulation of Rap GTPase activity (GO:0032317) | 2.91095141 |
| 65 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.90302203 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 2.88284342 |
| 67 | cerebellar Purkinje cell layer development (GO:0021680) | 2.84685334 |
| 68 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84179897 |
| 69 | neuron cell-cell adhesion (GO:0007158) | 2.83743893 |
| 70 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.82943483 |
| 71 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.82491845 |
| 72 | modulation by symbiont of host cellular process (GO:0044068) | 2.80036216 |
| 73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.79401027 |
| 74 | cell communication by electrical coupling (GO:0010644) | 2.79365962 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78220062 |
| 76 | glycine transport (GO:0015816) | 2.78187293 |
| 77 | gamma-aminobutyric acid transport (GO:0015812) | 2.77812195 |
| 78 | regulation of synaptic plasticity (GO:0048167) | 2.77577499 |
| 79 | thymic T cell selection (GO:0045061) | 2.76919948 |
| 80 | cell-cell junction maintenance (GO:0045217) | 2.76754101 |
| 81 | protein localization to endosome (GO:0036010) | 2.76459133 |
| 82 | activation of JUN kinase activity (GO:0007257) | 2.76110416 |
| 83 | nerve growth factor signaling pathway (GO:0038180) | 2.74873896 |
| 84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.73448258 |
| 85 | glutamate receptor signaling pathway (GO:0007215) | 2.72114010 |
| 86 | regulation of histone H3-K27 methylation (GO:0061085) | 2.71936908 |
| 87 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71285765 |
| 88 | signal complex assembly (GO:0007172) | 2.70959719 |
| 89 | regulation of early endosome to late endosome transport (GO:2000641) | 2.70901664 |
| 90 | negative thymic T cell selection (GO:0045060) | 2.68045613 |
| 91 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.68021352 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.67970508 |
| 93 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.67232149 |
| 94 | peptidyl-threonine phosphorylation (GO:0018107) | 2.66595401 |
| 95 | dopamine receptor signaling pathway (GO:0007212) | 2.66588909 |
| 96 | response to auditory stimulus (GO:0010996) | 2.66494459 |
| 97 | detection of bacterium (GO:0016045) | 2.65909433 |
| 98 | neuronal action potential propagation (GO:0019227) | 2.65314644 |
| 99 | adherens junction assembly (GO:0034333) | 2.65045576 |
| 100 | positive thymic T cell selection (GO:0045059) | 2.62432416 |
| 101 | histone H3-K36 demethylation (GO:0070544) | 2.62117968 |
| 102 | macrophage activation involved in immune response (GO:0002281) | 2.61726655 |
| 103 | vesicle transport along microtubule (GO:0047496) | 2.61363202 |
| 104 | response to type I interferon (GO:0034340) | 2.61176179 |
| 105 | modulation by virus of host process (GO:0019054) | 2.61109321 |
| 106 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.60972973 |
| 107 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.60872609 |
| 108 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.60179442 |
| 109 | regulation of postsynaptic membrane potential (GO:0060078) | 2.59550209 |
| 110 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.59456981 |
| 111 | negative regulation of cell size (GO:0045792) | 2.59416935 |
| 112 | stress fiber assembly (GO:0043149) | 2.59250595 |
| 113 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.59130678 |
| 114 | pre-miRNA processing (GO:0031054) | 2.58845036 |
| 115 | glial cell proliferation (GO:0014009) | 2.58489960 |
| 116 | focal adhesion assembly (GO:0048041) | 2.57254611 |
| 117 | cell-substrate adherens junction assembly (GO:0007045) | 2.57254611 |
| 118 | cellular response to virus (GO:0098586) | 2.57129964 |
| 119 | positive regulation of fibroblast migration (GO:0010763) | 2.56558168 |
| 120 | apoptotic process involved in morphogenesis (GO:0060561) | 2.56212356 |
| 121 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53606631 |
| 122 | modulation by symbiont of host defense response (GO:0052031) | 2.53606631 |
| 123 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53606631 |
| 124 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53606631 |
| 125 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53606631 |
| 126 | modulation by symbiont of host immune response (GO:0052553) | 2.53606631 |
| 127 | negative regulation of myotube differentiation (GO:0010832) | 2.53606017 |
| 128 | cellular response to type I interferon (GO:0071357) | 2.53552181 |
| 129 | type I interferon signaling pathway (GO:0060337) | 2.53552181 |
| 130 | T cell selection (GO:0045058) | 2.53532030 |
| 131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.53092096 |
| 132 | negative T cell selection (GO:0043383) | 2.53044897 |
| 133 | neurotransmitter transport (GO:0006836) | 2.52812733 |
| 134 | neuron recognition (GO:0008038) | 2.51705509 |
| 135 | positive regulation of protein dephosphorylation (GO:0035307) | 2.51563961 |
| 136 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.51244875 |
| 137 | regulation of neurotransmitter secretion (GO:0046928) | 2.49644258 |
| 138 | detection of other organism (GO:0098543) | 2.49142417 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.48763830 |
| 140 | peptidyl-threonine modification (GO:0018210) | 2.48001482 |
| 141 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.47742762 |
| 142 | response to nerve growth factor (GO:1990089) | 2.47742762 |
| 143 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.47535084 |
| 144 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46378422 |
| 145 | response to laminar fluid shear stress (GO:0034616) | 2.46071717 |
| 146 | neuron-neuron synaptic transmission (GO:0007270) | 2.45737477 |
| 147 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.45551177 |
| 148 | regulation of dendritic spine development (GO:0060998) | 2.45497574 |
| 149 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.45484680 |
| 150 | cerebellum development (GO:0021549) | 2.45125312 |
| 151 | adenosine receptor signaling pathway (GO:0001973) | 2.45015973 |
| 152 | positive regulation of type 2 immune response (GO:0002830) | 2.44890785 |
| 153 | membrane depolarization during action potential (GO:0086010) | 2.44512991 |
| 154 | positive regulation of protein deacetylation (GO:0090312) | 2.44289225 |
| 155 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.43925983 |
| 156 | neuronal ion channel clustering (GO:0045161) | 2.42971961 |
| 157 | establishment of nucleus localization (GO:0040023) | 2.42470137 |
| 158 | intraspecies interaction between organisms (GO:0051703) | 2.42444807 |
| 159 | social behavior (GO:0035176) | 2.42444807 |
| 160 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.42048090 |
| 161 | cell volume homeostasis (GO:0006884) | 2.39508148 |
| 162 | B cell receptor signaling pathway (GO:0050853) | 2.39277771 |
| 163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.38454247 |
| 164 | response to peptidoglycan (GO:0032494) | 2.38055979 |
| 165 | negative regulation of viral release from host cell (GO:1902187) | 2.35041570 |
| 166 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.33143142 |
| 167 | regulation of lipid kinase activity (GO:0043550) | 2.31498659 |
| 168 | barbed-end actin filament capping (GO:0051016) | 2.30829359 |
| 169 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.29083129 |
| 170 | positive regulation of Rac GTPase activity (GO:0032855) | 2.27570088 |
| 171 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.25601669 |
| 172 | histone H4 deacetylation (GO:0070933) | 2.23446938 |
| 173 | positive regulation of receptor recycling (GO:0001921) | 2.23122228 |
| 174 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.20975747 |
| 175 | regulation of necroptotic process (GO:0060544) | 2.19867856 |
| 176 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.19449392 |
| 177 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.16231376 |
| 178 | regulation of leukocyte degranulation (GO:0043300) | 2.15096258 |
| 179 | regulation of type 2 immune response (GO:0002828) | 2.13896024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.29482258 |
| 2 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.47475733 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.15969042 |
| 4 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.92091949 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.84592604 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.83860958 |
| 7 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.74442816 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.57874181 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.53088069 |
| 10 | KDM2B_26808549_Chip-Seq_K562_Human | 2.34403191 |
| 11 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.33718445 |
| 12 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.30006976 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.25666102 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.24314427 |
| 15 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22730816 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20766736 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.20401987 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18215417 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.16943673 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.16930710 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14135683 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09084467 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.06760748 |
| 24 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.05220879 |
| 25 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 2.00176874 |
| 26 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.98359640 |
| 27 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.95985208 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92821885 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.92766810 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91952771 |
| 31 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.91298214 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90240873 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88907174 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79616507 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79094782 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73482218 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.69837979 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.66310021 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65477131 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61773397 |
| 41 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.58129516 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.58129516 |
| 43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57576298 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.57384258 |
| 45 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.57350186 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56611587 |
| 47 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.56607967 |
| 48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.55081387 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51045970 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.50778966 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48721088 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.46836410 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46788356 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.45525718 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44372116 |
| 56 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.42798267 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.41775145 |
| 58 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40686210 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37807323 |
| 60 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.37395940 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37389169 |
| 62 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.37175823 |
| 63 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.36909494 |
| 64 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.35801458 |
| 65 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35256518 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34954319 |
| 67 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.34855756 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32512950 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31312645 |
| 70 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30662944 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29402676 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.28982700 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.28134115 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25844582 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25297422 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24179860 |
| 77 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21560744 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21300090 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20410923 |
| 80 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18701611 |
| 81 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18245753 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17485379 |
| 83 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17259430 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17121011 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16715454 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16533394 |
| 87 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15837219 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14615874 |
| 89 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13800406 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13519091 |
| 91 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12155243 |
| 92 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11438801 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11001619 |
| 94 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.10882883 |
| 95 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10871333 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10841423 |
| 97 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10444698 |
| 98 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.10121181 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09468377 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09215327 |
| 101 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08696994 |
| 102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08565597 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.08453545 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05730192 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05508118 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04280354 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04099989 |
| 108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03904558 |
| 109 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.03814939 |
| 110 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02695714 |
| 111 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02303746 |
| 112 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.02066072 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00194874 |
| 114 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99415102 |
| 115 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99168735 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99062846 |
| 117 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98764089 |
| 118 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97306894 |
| 119 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95017658 |
| 120 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94736117 |
| 121 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94025322 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93749455 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92963125 |
| 124 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.92561632 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92026037 |
| 126 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91362515 |
| 127 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.91322967 |
| 128 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90942718 |
| 129 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89349877 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87879643 |
| 131 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.87783645 |
| 132 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86742918 |
| 133 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.86592276 |
| 134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86514094 |
| 135 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86445352 |
| 136 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.85979631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.74203224 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.58862593 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.40282443 |
| 4 | MP0004270_analgesia | 3.11203065 |
| 5 | MP0003436_decreased_susceptibility_to | 2.96174832 |
| 6 | MP0003303_peritoneal_inflammation | 2.90211280 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.86715408 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.85984210 |
| 9 | MP0003880_abnormal_central_pattern | 2.71853071 |
| 10 | MP0008961_abnormal_basal_metabolism | 2.66369753 |
| 11 | MP0009745_abnormal_behavioral_response | 2.56454390 |
| 12 | MP0004510_myositis | 2.50278983 |
| 13 | MP0002064_seizures | 2.50093139 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.47580027 |
| 15 | MP0002822_catalepsy | 2.46596934 |
| 16 | MP0004858_abnormal_nervous_system | 2.35655559 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.32371783 |
| 18 | MP0008569_lethality_at_weaning | 2.21286501 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.20546790 |
| 20 | MP0005451_abnormal_body_composition | 2.17664142 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.13781214 |
| 22 | MP0009046_muscle_twitch | 2.08394852 |
| 23 | MP0004947_skin_inflammation | 2.03083473 |
| 24 | MP0003091_abnormal_cell_migration | 1.97367850 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.92901102 |
| 26 | MP0005409_darkened_coat_color | 1.87332230 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.85782888 |
| 28 | MP0008260_abnormal_autophagy | 1.81639422 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.79674608 |
| 30 | MP0003329_amyloid_beta_deposits | 1.77185874 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 1.70918480 |
| 32 | MP0005025_abnormal_response_to | 1.68694086 |
| 33 | MP0001486_abnormal_startle_reflex | 1.66603800 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.66541925 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.64553165 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.60317240 |
| 37 | MP0009840_abnormal_foam_cell | 1.59780866 |
| 38 | MP0000778_abnormal_nervous_system | 1.53761400 |
| 39 | MP0002272_abnormal_nervous_system | 1.53473884 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.52921436 |
| 41 | MP0002249_abnormal_larynx_morphology | 1.50325590 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.50188047 |
| 43 | MP0003787_abnormal_imprinting | 1.49470818 |
| 44 | MP0003879_abnormal_hair_cell | 1.48879535 |
| 45 | MP0004885_abnormal_endolymph | 1.48295104 |
| 46 | MP0002419_abnormal_innate_immunity | 1.47152178 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.45458844 |
| 48 | MP0001970_abnormal_pain_threshold | 1.45190077 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.45075930 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.43900396 |
| 51 | MP0002184_abnormal_innervation | 1.42592148 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.42224075 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.40730394 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.40200484 |
| 55 | MP0003279_aneurysm | 1.38598359 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.37607083 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.35610267 |
| 58 | MP0000955_abnormal_spinal_cord | 1.34911530 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.32872153 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.32003050 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.30067731 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.28966551 |
| 63 | MP0002735_abnormal_chemical_nociception | 1.28769939 |
| 64 | MP0003690_abnormal_glial_cell | 1.28311766 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.28286874 |
| 66 | MP0002933_joint_inflammation | 1.26011814 |
| 67 | MP0003866_abnormal_defecation | 1.24212090 |
| 68 | MP0005670_abnormal_white_adipose | 1.23342934 |
| 69 | MP0000858_altered_metastatic_potential | 1.22338339 |
| 70 | MP0005310_abnormal_salivary_gland | 1.21105673 |
| 71 | MP0005387_immune_system_phenotype | 1.20408945 |
| 72 | MP0001790_abnormal_immune_system | 1.20408945 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.20396460 |
| 74 | MP0005386_behavior/neurological_phenoty | 1.19892301 |
| 75 | MP0004924_abnormal_behavior | 1.19892301 |
| 76 | MP0001835_abnormal_antigen_presentation | 1.17429009 |
| 77 | MP0002736_abnormal_nociception_after | 1.17142005 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 1.14573642 |
| 79 | MP0008874_decreased_physiological_sensi | 1.14112536 |
| 80 | MP0001800_abnormal_humoral_immune | 1.12878284 |
| 81 | MP0005375_adipose_tissue_phenotype | 1.12734438 |
| 82 | MP0000685_abnormal_immune_system | 1.12000585 |
| 83 | MP0002882_abnormal_neuron_morphology | 1.09665914 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 1.09130993 |
| 85 | MP0002405_respiratory_system_inflammati | 1.08251274 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 1.07972841 |
| 87 | MP0005499_abnormal_olfactory_system | 1.07945645 |
| 88 | MP0005394_taste/olfaction_phenotype | 1.07945645 |
| 89 | MP0002152_abnormal_brain_morphology | 1.07128993 |
| 90 | MP0003075_altered_response_to | 1.06822906 |
| 91 | MP0002653_abnormal_ependyma_morphology | 1.06795630 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 1.04787559 |
| 93 | MP0003763_abnormal_thymus_physiology | 1.03439723 |
| 94 | MP0000751_myopathy | 1.02731751 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 1.01937140 |
| 96 | MP0009785_altered_susceptibility_to | 1.00617148 |
| 97 | MP0000604_amyloidosis | 1.00274979 |
| 98 | MP0003633_abnormal_nervous_system | 1.00045928 |
| 99 | MP0004381_abnormal_hair_follicle | 0.99428949 |
| 100 | MP0002796_impaired_skin_barrier | 0.99067117 |
| 101 | MP0002398_abnormal_bone_marrow | 0.98145744 |
| 102 | MP0000733_abnormal_muscle_development | 0.96831760 |
| 103 | MP0005166_decreased_susceptibility_to | 0.95176535 |
| 104 | MP0006082_CNS_inflammation | 0.93468545 |
| 105 | MP0001958_emphysema | 0.92019162 |
| 106 | MP0002429_abnormal_blood_cell | 0.90267327 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.89517993 |
| 108 | MP0003724_increased_susceptibility_to | 0.89104776 |
| 109 | MP0001873_stomach_inflammation | 0.88747154 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.88662966 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.87388607 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.86223729 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.86190107 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.85658802 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.85250358 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.85250358 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.84432087 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.83257107 |
| 119 | MP0008872_abnormal_physiological_respon | 0.81696302 |
| 120 | MP0002420_abnormal_adaptive_immunity | 0.80968174 |
| 121 | MP0001853_heart_inflammation | 0.80680115 |
| 122 | MP0003631_nervous_system_phenotype | 0.80234374 |
| 123 | MP0005023_abnormal_wound_healing | 0.80123431 |
| 124 | MP0001819_abnormal_immune_cell | 0.79986137 |
| 125 | MP0005000_abnormal_immune_tolerance | 0.79733317 |
| 126 | MP0003123_paternal_imprinting | 0.79641812 |
| 127 | MP0005390_skeleton_phenotype | 0.78663091 |
| 128 | MP0009278_abnormal_bone_marrow | 0.78180233 |
| 129 | MP0002452_abnormal_antigen_presenting | 0.77744312 |
| 130 | MP0004130_abnormal_muscle_cell | 0.77736953 |
| 131 | MP0001502_abnormal_circadian_rhythm | 0.77465445 |
| 132 | MP0000920_abnormal_myelination | 0.76890457 |
| 133 | MP0001851_eye_inflammation | 0.76330601 |
| 134 | MP0005621_abnormal_cell_physiology | 0.75478028 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.75021751 |
| 136 | MP0002723_abnormal_immune_serum | 0.74805448 |
| 137 | MP0008770_decreased_survivor_rate | 0.74673668 |
| 138 | MP0000716_abnormal_immune_system | 0.74503379 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.74443637 |
| 140 | MP0008004_abnormal_stomach_pH | 0.74230480 |
| 141 | MP0005671_abnormal_response_to | 0.72971893 |
| 142 | MP0003861_abnormal_nervous_system | 0.72724123 |
| 143 | MP0005174_abnormal_tail_pigmentation | 0.70169198 |
| 144 | MP0010352_gastrointestinal_tract_polyps | 0.69819807 |
| 145 | MP0003646_muscle_fatigue | 0.63612311 |
| 146 | MP0010769_abnormal_survival | 0.63170018 |
| 147 | MP0003045_fibrosis | 0.62975783 |
| 148 | MP0002234_abnormal_pharynx_morphology | 0.60026547 |
| 149 | MP0010768_mortality/aging | 0.59372475 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.57854425 |
| 151 | MP0001849_ear_inflammation | 0.57329286 |
| 152 | MP0005535_abnormal_body_temperature | 0.57128364 |
| 153 | MP0002722_abnormal_immune_system | 0.56799156 |
| 154 | MP0002083_premature_death | 0.56402509 |
| 155 | MP0003634_abnormal_glial_cell | 0.54890326 |
| 156 | MP0003283_abnormal_digestive_organ | 0.54701787 |
| 157 | MP0010770_preweaning_lethality | 0.53472235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.79415345 |
| 2 | Visual hallucinations (HP:0002367) | 4.06472155 |
| 3 | Supranuclear gaze palsy (HP:0000605) | 3.69839508 |
| 4 | Focal seizures (HP:0007359) | 3.67470778 |
| 5 | Focal motor seizures (HP:0011153) | 3.66123145 |
| 6 | Papilledema (HP:0001085) | 3.63124861 |
| 7 | Hyperacusis (HP:0010780) | 3.59645528 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 3.53397301 |
| 9 | Broad face (HP:0000283) | 3.39864982 |
| 10 | Dysmetric saccades (HP:0000641) | 3.17223680 |
| 11 | Insomnia (HP:0100785) | 3.01011105 |
| 12 | Cerebral aneurysm (HP:0004944) | 3.00485332 |
| 13 | Ankle clonus (HP:0011448) | 2.89293992 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 2.84993127 |
| 15 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.82927796 |
| 16 | Abnormal social behavior (HP:0012433) | 2.81360637 |
| 17 | Impaired social interactions (HP:0000735) | 2.81360637 |
| 18 | Poor eye contact (HP:0000817) | 2.81225199 |
| 19 | Pointed chin (HP:0000307) | 2.80596333 |
| 20 | Amyotrophic lateral sclerosis (HP:0007354) | 2.80265216 |
| 21 | Urinary urgency (HP:0000012) | 2.77888942 |
| 22 | Thin bony cortex (HP:0002753) | 2.76842184 |
| 23 | Genetic anticipation (HP:0003743) | 2.74597214 |
| 24 | Annular pancreas (HP:0001734) | 2.72038032 |
| 25 | Emphysema (HP:0002097) | 2.69765654 |
| 26 | Obstructive sleep apnea (HP:0002870) | 2.68833425 |
| 27 | Abnormality of binocular vision (HP:0011514) | 2.65571101 |
| 28 | Diplopia (HP:0000651) | 2.65571101 |
| 29 | Apathy (HP:0000741) | 2.64887768 |
| 30 | Eczematoid dermatitis (HP:0000976) | 2.64086702 |
| 31 | Mutism (HP:0002300) | 2.62667035 |
| 32 | Depression (HP:0000716) | 2.61580303 |
| 33 | Progressive cerebellar ataxia (HP:0002073) | 2.61564883 |
| 34 | Action tremor (HP:0002345) | 2.59808142 |
| 35 | Neurofibrillary tangles (HP:0002185) | 2.57257930 |
| 36 | Impaired smooth pursuit (HP:0007772) | 2.53530409 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 2.53309572 |
| 38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.51698742 |
| 39 | Postural instability (HP:0002172) | 2.51592583 |
| 40 | Macroorchidism (HP:0000053) | 2.45951855 |
| 41 | Hemiplegia (HP:0002301) | 2.44835560 |
| 42 | Stereotypic behavior (HP:0000733) | 2.43904034 |
| 43 | Elfin facies (HP:0004428) | 2.42379845 |
| 44 | Diminished motivation (HP:0000745) | 2.41082493 |
| 45 | Epileptic encephalopathy (HP:0200134) | 2.38318344 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.26886423 |
| 47 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26361510 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.20119489 |
| 49 | Flat acetabular roof (HP:0003180) | 2.19878552 |
| 50 | Truncal ataxia (HP:0002078) | 2.18883308 |
| 51 | Absence seizures (HP:0002121) | 2.14346488 |
| 52 | Broad-based gait (HP:0002136) | 2.13180730 |
| 53 | Overriding aorta (HP:0002623) | 2.12516640 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.11665912 |
| 55 | Nuclear cataract (HP:0100018) | 2.10704702 |
| 56 | Neoplasm of the heart (HP:0100544) | 2.09857131 |
| 57 | Spastic gait (HP:0002064) | 2.07346607 |
| 58 | J-shaped sella turcica (HP:0002680) | 2.07299458 |
| 59 | Lower limb amyotrophy (HP:0007210) | 2.07158540 |
| 60 | Long palpebral fissure (HP:0000637) | 2.06278803 |
| 61 | Shallow orbits (HP:0000586) | 2.04906756 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.03990736 |
| 63 | Gingivitis (HP:0000230) | 2.03809018 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.03047320 |
| 65 | Rapidly progressive (HP:0003678) | 2.01794140 |
| 66 | Nasal polyposis (HP:0100582) | 2.01709508 |
| 67 | Febrile seizures (HP:0002373) | 2.01333401 |
| 68 | Heterotopia (HP:0002282) | 2.01021003 |
| 69 | Polygenic inheritance (HP:0010982) | 2.00730480 |
| 70 | Bundle branch block (HP:0011710) | 2.00689685 |
| 71 | Papilloma (HP:0012740) | 2.00548990 |
| 72 | Verrucae (HP:0200043) | 2.00548990 |
| 73 | Metaphyseal cupping (HP:0003021) | 2.00548901 |
| 74 | Atonic seizures (HP:0010819) | 2.00446853 |
| 75 | Vertebral arch anomaly (HP:0008438) | 2.00432382 |
| 76 | Neuronal loss in central nervous system (HP:0002529) | 1.99963213 |
| 77 | Abnormality of the fingertips (HP:0001211) | 1.99537452 |
| 78 | Hypercortisolism (HP:0001578) | 1.98877117 |
| 79 | Abnormal eating behavior (HP:0100738) | 1.98247078 |
| 80 | Abnormality of the thoracic spine (HP:0100711) | 1.97941655 |
| 81 | Inappropriate behavior (HP:0000719) | 1.97129554 |
| 82 | Restrictive lung disease (HP:0002091) | 1.95939679 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 1.95871793 |
| 84 | Bronchomalacia (HP:0002780) | 1.94345313 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 1.94293461 |
| 86 | Malnutrition (HP:0004395) | 1.94032365 |
| 87 | Hemiparesis (HP:0001269) | 1.93522702 |
| 88 | Ankyloglossia (HP:0010296) | 1.92606441 |
| 89 | Colitis (HP:0002583) | 1.92362120 |
| 90 | Cervical subluxation (HP:0003308) | 1.92295811 |
| 91 | Dysmetria (HP:0001310) | 1.92245679 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.92173903 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 1.92155656 |
| 94 | Slow saccadic eye movements (HP:0000514) | 1.91855071 |
| 95 | Amblyopia (HP:0000646) | 1.91326944 |
| 96 | Dialeptic seizures (HP:0011146) | 1.90221562 |
| 97 | Agammaglobulinemia (HP:0004432) | 1.89692670 |
| 98 | Large eyes (HP:0001090) | 1.89591535 |
| 99 | Megalencephaly (HP:0001355) | 1.88678338 |
| 100 | Distal upper limb amyotrophy (HP:0007149) | 1.87619577 |
| 101 | Upper limb amyotrophy (HP:0009129) | 1.87619577 |
| 102 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87445804 |
| 103 | Progressive inability to walk (HP:0002505) | 1.87427211 |
| 104 | Aneurysm (HP:0002617) | 1.86664267 |
| 105 | Insidious onset (HP:0003587) | 1.86136419 |
| 106 | Termporal pattern (HP:0011008) | 1.86136419 |
| 107 | Onion bulb formation (HP:0003383) | 1.86120698 |
| 108 | Deep palmar crease (HP:0006191) | 1.85897114 |
| 109 | Cellulitis (HP:0100658) | 1.85177377 |
| 110 | Intellectual disability, profound (HP:0002187) | 1.84497006 |
| 111 | Abnormality of macrophages (HP:0004311) | 1.83971375 |
| 112 | Generalized tonic-clonic seizures (HP:0002069) | 1.82918380 |
| 113 | Gastrointestinal inflammation (HP:0004386) | 1.82902573 |
| 114 | Thoracic kyphosis (HP:0002942) | 1.82633124 |
| 115 | Dysdiadochokinesis (HP:0002075) | 1.82481879 |
| 116 | Abnormality of the astrocytes (HP:0100707) | 1.82354092 |
| 117 | Astrocytoma (HP:0009592) | 1.82354092 |
| 118 | Axonal loss (HP:0003447) | 1.81664973 |
| 119 | Gaze-evoked nystagmus (HP:0000640) | 1.80835699 |
| 120 | Renovascular hypertension (HP:0100817) | 1.80793813 |
| 121 | Disproportionate tall stature (HP:0001519) | 1.80379745 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.79996020 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79996020 |
| 124 | Bradykinesia (HP:0002067) | 1.78847523 |
| 125 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78649320 |
| 126 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78381394 |
| 127 | Chronic otitis media (HP:0000389) | 1.78009833 |
| 128 | Stridor (HP:0010307) | 1.77925840 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 1.76707177 |
| 130 | Sacral dimple (HP:0000960) | 1.76128509 |
| 131 | Resting tremor (HP:0002322) | 1.75956114 |
| 132 | Recurrent bronchitis (HP:0002837) | 1.75770697 |
| 133 | Increased connective tissue (HP:0009025) | 1.75704627 |
| 134 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.75580602 |
| 135 | Meningitis (HP:0001287) | 1.74732285 |
| 136 | Torticollis (HP:0000473) | 1.74121388 |
| 137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73944807 |
| 138 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73944807 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73944807 |
| 140 | Easy fatigability (HP:0003388) | 1.73862276 |
| 141 | Mediastinal lymphadenopathy (HP:0100721) | 1.73657349 |
| 142 | Fatigue (HP:0012378) | 1.73490476 |
| 143 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.73455257 |
| 144 | Turricephaly (HP:0000262) | 1.73087741 |
| 145 | Recurrent viral infections (HP:0004429) | 1.72054244 |
| 146 | Recurrent bacterial skin infections (HP:0005406) | 1.72002327 |
| 147 | Long eyelashes (HP:0000527) | 1.70834714 |
| 148 | Inflammation of the large intestine (HP:0002037) | 1.70763102 |
| 149 | Hyperparathyroidism (HP:0000843) | 1.70419153 |
| 150 | Frequent falls (HP:0002359) | 1.69743770 |
| 151 | Generalized hypotonia (HP:0001290) | 1.69628205 |
| 152 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.68866068 |
| 153 | Recurrent abscess formation (HP:0002722) | 1.68419886 |
| 154 | Urethral obstruction (HP:0000796) | 1.68096250 |
| 155 | Mitral regurgitation (HP:0001653) | 1.68024640 |
| 156 | Increased IgE level (HP:0003212) | 1.67791803 |
| 157 | Intention tremor (HP:0002080) | 1.66826254 |
| 158 | Abnormality of saccadic eye movements (HP:0000570) | 1.66347383 |
| 159 | Protrusio acetabuli (HP:0003179) | 1.65259412 |
| 160 | Vasculitis (HP:0002633) | 1.65236943 |
| 161 | Achilles tendon contracture (HP:0001771) | 1.64372281 |
| 162 | Loss of speech (HP:0002371) | 1.60393248 |
| 163 | Precocious puberty (HP:0000826) | 1.59497017 |
| 164 | Hand muscle atrophy (HP:0009130) | 1.59201253 |
| 165 | Asymmetric septal hypertrophy (HP:0001670) | 1.58775056 |
| 166 | Dislocated radial head (HP:0003083) | 1.54316358 |
| 167 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.53834577 |
| 168 | Atelectasis (HP:0100750) | 1.52176604 |
| 169 | Fragile skin (HP:0001030) | 1.51347115 |
| 170 | Chronic obstructive pulmonary disease (HP:0006510) | 1.51276514 |
| 171 | Obstructive lung disease (HP:0006536) | 1.51276514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.75954135 |
| 2 | MARK1 | 3.02951349 |
| 3 | SIK2 | 3.01016000 |
| 4 | SIK1 | 3.00492445 |
| 5 | PRKD3 | 2.75331372 |
| 6 | TRIB3 | 2.70885709 |
| 7 | SMG1 | 2.62020422 |
| 8 | EEF2K | 2.49074163 |
| 9 | MAP4K1 | 2.39793016 |
| 10 | EPHA4 | 2.38867086 |
| 11 | TAOK1 | 2.22556640 |
| 12 | NTRK3 | 2.19845647 |
| 13 | DAPK2 | 2.16793596 |
| 14 | PAK6 | 2.00839958 |
| 15 | FGFR4 | 1.98627913 |
| 16 | ALK | 1.94751975 |
| 17 | RIPK4 | 1.89768073 |
| 18 | KSR2 | 1.89646141 |
| 19 | MAP3K10 | 1.87486416 |
| 20 | NTRK2 | 1.85373083 |
| 21 | IRAK3 | 1.84547588 |
| 22 | CAMKK1 | 1.80914434 |
| 23 | ICK | 1.78312422 |
| 24 | MINK1 | 1.72589670 |
| 25 | TYRO3 | 1.68308053 |
| 26 | PKN2 | 1.65718195 |
| 27 | MAP3K4 | 1.56710897 |
| 28 | FES | 1.43548735 |
| 29 | MST1R | 1.43365605 |
| 30 | EPHA2 | 1.40431137 |
| 31 | TYK2 | 1.39902407 |
| 32 | CDK12 | 1.38260128 |
| 33 | SIK3 | 1.33095426 |
| 34 | MAP3K13 | 1.25135185 |
| 35 | MAP3K14 | 1.25108868 |
| 36 | CDK5 | 1.24015259 |
| 37 | DDR2 | 1.23568437 |
| 38 | PRKCH | 1.23174567 |
| 39 | UHMK1 | 1.21356054 |
| 40 | MARK2 | 1.19218773 |
| 41 | TBK1 | 1.16336500 |
| 42 | STK11 | 1.15834757 |
| 43 | RIPK1 | 1.14687637 |
| 44 | DAPK1 | 1.14605982 |
| 45 | BLK | 1.13589642 |
| 46 | CAMK1G | 1.13324628 |
| 47 | STK38 | 1.12209941 |
| 48 | KSR1 | 1.10689719 |
| 49 | GRK6 | 1.09593816 |
| 50 | RET | 1.09041159 |
| 51 | PRPF4B | 1.07523878 |
| 52 | MAP3K11 | 1.07061482 |
| 53 | MAP3K7 | 1.05139007 |
| 54 | CDK19 | 1.00523277 |
| 55 | TESK1 | 0.99865118 |
| 56 | NTRK1 | 0.95479006 |
| 57 | TAOK2 | 0.90640264 |
| 58 | ZAP70 | 0.88750615 |
| 59 | MAP2K3 | 0.88361546 |
| 60 | SGK3 | 0.87779113 |
| 61 | SYK | 0.86316328 |
| 62 | IRAK4 | 0.85598114 |
| 63 | MAP2K4 | 0.85596215 |
| 64 | DMPK | 0.85394861 |
| 65 | SCYL2 | 0.85316734 |
| 66 | PDK1 | 0.84697727 |
| 67 | TTN | 0.83926714 |
| 68 | NME2 | 0.82970085 |
| 69 | TNK2 | 0.77993306 |
| 70 | PNCK | 0.77422920 |
| 71 | RPS6KA2 | 0.75370169 |
| 72 | MAP2K7 | 0.75176237 |
| 73 | HCK | 0.74156628 |
| 74 | CSK | 0.73650977 |
| 75 | MAP3K3 | 0.73259711 |
| 76 | CDC42BPA | 0.72991650 |
| 77 | MAPK12 | 0.71938248 |
| 78 | PHKG2 | 0.71842282 |
| 79 | PHKG1 | 0.71842282 |
| 80 | MAP3K6 | 0.71393817 |
| 81 | CHUK | 0.70694997 |
| 82 | MAP3K2 | 0.70671688 |
| 83 | MAPK15 | 0.70048534 |
| 84 | CAMK1D | 0.69546442 |
| 85 | ERN1 | 0.69489624 |
| 86 | IKBKE | 0.68922253 |
| 87 | BMX | 0.67941727 |
| 88 | CAMK1 | 0.67406037 |
| 89 | JAK1 | 0.67042966 |
| 90 | MAP3K1 | 0.66305093 |
| 91 | BTK | 0.65931692 |
| 92 | LRRK2 | 0.65410456 |
| 93 | MAPK11 | 0.64516255 |
| 94 | PTK6 | 0.63701816 |
| 95 | IRAK2 | 0.63417643 |
| 96 | RPS6KC1 | 0.62763070 |
| 97 | RPS6KL1 | 0.62763070 |
| 98 | CDK15 | 0.62122413 |
| 99 | MAPK7 | 0.61572122 |
| 100 | RAF1 | 0.61269571 |
| 101 | CDK18 | 0.58885415 |
| 102 | PRKD2 | 0.58539161 |
| 103 | CDK11A | 0.58031838 |
| 104 | CAMK4 | 0.57591890 |
| 105 | FGFR3 | 0.57021344 |
| 106 | PDPK1 | 0.56916460 |
| 107 | HIPK2 | 0.55215522 |
| 108 | MAPK13 | 0.55103052 |
| 109 | CDK4 | 0.54447787 |
| 110 | FYN | 0.53459908 |
| 111 | PRKCG | 0.50294234 |
| 112 | PTK2 | 0.49966134 |
| 113 | JAK2 | 0.49230837 |
| 114 | PRKCZ | 0.48404324 |
| 115 | GRK5 | 0.47791971 |
| 116 | JAK3 | 0.47358938 |
| 117 | CDK14 | 0.47138302 |
| 118 | RPS6KA6 | 0.45402163 |
| 119 | ARAF | 0.44661965 |
| 120 | LMTK2 | 0.43808634 |
| 121 | PAK4 | 0.42561502 |
| 122 | RPS6KA1 | 0.42185314 |
| 123 | SGK1 | 0.41351449 |
| 124 | MAPK8 | 0.41211813 |
| 125 | CSF1R | 0.40821301 |
| 126 | DYRK1A | 0.40211548 |
| 127 | MAP2K2 | 0.39892269 |
| 128 | RPS6KA3 | 0.39610155 |
| 129 | IKBKB | 0.39450737 |
| 130 | MAPK4 | 0.38729276 |
| 131 | LATS2 | 0.38027862 |
| 132 | FGR | 0.37989222 |
| 133 | DYRK1B | 0.37809164 |
| 134 | MTOR | 0.37569727 |
| 135 | MAP2K6 | 0.37455272 |
| 136 | PDGFRB | 0.37117457 |
| 137 | MAPK10 | 0.36813888 |
| 138 | PDGFRA | 0.36417121 |
| 139 | CSNK1G2 | 0.36376067 |
| 140 | NEK1 | 0.34700796 |
| 141 | EPHB1 | 0.34415148 |
| 142 | PRKD1 | 0.32500632 |
| 143 | SGK2 | 0.32323259 |
| 144 | SGK223 | 0.31966231 |
| 145 | SGK494 | 0.31966231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.15329406 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.08410539 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06980543 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05459083 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.99629845 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.83814622 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.76856469 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.72453222 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.65728251 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65324026 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.60145332 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.60055369 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59361504 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56818440 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.56761458 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56520597 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49486975 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.48412541 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.47699812 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45652320 |
| 21 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.44582249 |
| 22 | Glioma_Homo sapiens_hsa05214 | 1.43843542 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43327197 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42189402 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39490123 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38503532 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38372515 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.34989809 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32139688 |
| 30 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.30136564 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29664209 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28947020 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28064028 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.27519633 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26943422 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.25018594 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24439701 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23600781 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22370656 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20321624 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.20226304 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19970768 |
| 43 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.18977302 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18626937 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.18586159 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18352689 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16876722 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.15639057 |
| 49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.15283278 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 1.14888976 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13950200 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13423705 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12180845 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11398994 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.11189901 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09196178 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08586279 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08074410 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06542071 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 1.06490095 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04823676 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01357696 |
| 63 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00354786 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99839139 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99469279 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.99009391 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.98615325 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97061697 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96417294 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.96210233 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93726069 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93720111 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 0.93396350 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92777250 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.91690215 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91492935 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.91404501 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91114750 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90343829 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.90180654 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90038206 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89846200 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86040368 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.84701030 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84097868 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.83834034 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83398929 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81474517 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.80274504 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79437120 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79144745 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77445375 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75864433 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75578600 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.75493318 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75393934 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75377964 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75082021 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.74359326 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73741213 |
| 101 | Asthma_Homo sapiens_hsa05310 | 0.73582959 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72859805 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72668595 |
| 104 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72051193 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71929785 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.71820839 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71441922 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71371585 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70176416 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.69541758 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.69457557 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.67813276 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67388999 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.67264134 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66843791 |
| 116 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65901861 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.64861304 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63954098 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63619745 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61887389 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.61810716 |
| 122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60415322 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60369570 |
| 124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59496405 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58935953 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58900515 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58685347 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58205189 |
| 129 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56649591 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55994291 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55543845 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54975399 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54829464 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.54460903 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53878990 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53866784 |
| 137 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53779964 |
| 138 | Salmonella infection_Homo sapiens_hsa05132 | 0.53572552 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53479781 |

